Cellular immunotherapy for acute myeloid leukemia using dendritic cells pulsed with WT1 peptide and zoledronate
Phase of Trial: Phase I/II
Latest Information Update: 26 Dec 2009
At a glance
- Drugs WT1 peptide-loaded dendritic cell vaccine; WT1 peptide-loaded dendritic cell vaccine; Zoledronic acid; Zoledronic acid
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 26 Dec 2009 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 08 Jun 2009 New trial record.